TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Code Blue Outcomes & Process Improvement Through Leadership Optimization Using Teleintensivists-Simulation
Brief Summary: This multicenter randomized trial will employ in-situ cardiac arrest simulations ("mock codes") to test whether using telemedicine technology to add an intensive care physician as the "copilot" for cardiac arrest resuscitation teams influences chest compression quality, resuscitation protocol adherence, team function, and provider experience.


Options:
A: Arm Label: Retreat; Type: EXPERIMENTAL; Interventions: Other: Retreat | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Retreat; Assigned to Arm(s): Retreat
B: Arm Label: One-to-One Coaching; Type: EXPERIMENTAL; Interventions: Behavioral: Professional coaching | Arm Label: Group Coaching; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Professional coaching | Arm Label: Group Coaching Waitlist; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Professional coaching; Assigned to Arm(s): Group Coaching, One-to-One Coaching
C: Arm Label: Tele-intensivist consultation; Type: EXPERIMENTAL; Interventions: Other: Tele-intensivist consultation | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Simulated "observation" by ICU physician | Intervention Type: OTHER; Name: Tele-intensivist consultation; Assigned to Arm(s): Tele-intensivist consultation | Intervention Type: OTHER; Name: Simulated "observation" by ICU physician; Assigned to Arm(s): Control
D: Intervention Type: BEHAVIORAL; Name: Leadership development program educational intervention; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mental Health in Adults and Children: Frugal Innovations
Brief Summary: This stepped wedge, randomized controlled trial will test the effectiveness of a Supported Self-Management intervention for depression among adults in Vietnam. The intervention will be delivered at the community level in 8 Vietnamese provinces by primary care providers and social workers. The intervention group will receive the Supported Self-Management intervention, while the control group will receive enhanced treatment as usual. The primary outcome measure for depression is the Self-Reporting Questionnaire-20 (SRQ-20). The World Health Organization's Disability Assessment Scale (WHODAS 2.00 and the CAGE (Concern/Cut-down, Anger, Guilt, and Eye-opener) measures are also used to assess functional ability and alcohol misuse.


Options:
A: Arm Label: Wait List Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Trauma Focused Cognitive Behavioral Therapy | Intervention Type: BEHAVIORAL; Name: Trauma Focused Cognitive Behavioral Therapy; Assigned to Arm(s): Intervention Group
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Supported Self-Management | Arm Label: Control; Type: OTHER; Interventions: Other: Enhanced treatment as usual | Intervention Type: OTHER; Name: Supported Self-Management; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Enhanced treatment as usual; Assigned to Arm(s): Control
C: Arm Label: Depression Care; Type: EXPERIMENTAL; Interventions: Combination Product: evidence-based depression treatment | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: COMBINATION_PRODUCT; Name: evidence-based depression treatment; Assigned to Arm(s): Depression Care
D: Arm Label: CAMH training; Type: EXPERIMENTAL; Interventions: Other: CAMH training | Arm Label: No CAMH training; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: CAMH training; Assigned to Arm(s): CAMH training

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Placebo- and Active-controlled Multi-country, Multi-centre Parallel Group Study to Evaluate the Efficacy and Safety of a Fixed Dose Combination of 400 mg Ibuprofen and 100 mg Caffeine Compared to Ibuprofen 400 mg and Placebo in Patients With Acute Lower Back or Neck Pain.
Brief Summary: To assess the efficacy and safety of a 400 mg ibuprofen/100 mg caffeine tablet in comparison to a 400 mg ibuprofen tablet for the treatment of acute lower back or neck pain. To assess the safety and tolerability of a 400 mg ibuprofen/100 mg caffeine tablet in comparison to a 400 mg ibuprofen tablet and a placebo tablet.


Options:
A: Arm Label: acupuncture; Type: EXPERIMENTAL; Interventions: Other: acupuncture, injection | Arm Label: injections of diclofenac; Type: ACTIVE_COMPARATOR; Interventions: Other: acupuncture, injection | Intervention Type: OTHER; Name: acupuncture, injection; Assigned to Arm(s): acupuncture, injections of diclofenac
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Naproxen, Drug: Placebo | Arm Label: Orphenadrine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Orphenadrine, Drug: Naproxen | Arm Label: Methocarbamol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Methocarbamol, Drug: Naproxen | Intervention Type: DRUG; Name: Orphenadrine; Assigned to Arm(s): Orphenadrine | Intervention Type: DRUG; Name: Methocarbamol; Assigned to Arm(s): Methocarbamol | Intervention Type: DRUG; Name: Naproxen; Assigned to Arm(s): Methocarbamol, Orphenadrine, Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: ibuprofen + caffeine; Type: EXPERIMENTAL; Interventions: Drug: ibuprofen, Drug: caffeine | Arm Label: ibuprofen; Type: ACTIVE_COMPARATOR; Interventions: Drug: ibuprofen | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: ibuprofen; Assigned to Arm(s): ibuprofen, ibuprofen + caffeine | Intervention Type: DRUG; Name: caffeine; Assigned to Arm(s): ibuprofen + caffeine | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): placebo
D: Arm Label: Opioid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Naproxen, Drug: Oxycodone/ acetaminophen | Arm Label: Skeletal muscle relaxant; Type: ACTIVE_COMPARATOR; Interventions: Drug: Naproxen, Drug: Cyclobenzaprine | Arm Label: Naproxen alone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Naproxen | Intervention Type: DRUG; Name: Naproxen; Assigned to Arm(s): Naproxen alone, Opioid, Skeletal muscle relaxant | Intervention Type: DRUG; Name: Cyclobenzaprine; Assigned to Arm(s): Skeletal muscle relaxant | Intervention Type: DRUG; Name: Oxycodone/ acetaminophen; Assigned to Arm(s): Opioid

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Pragmatic Trial Comparing the Clinical and Cost Effectiveness of Lithium and Quetiapine Augmentation in Treatment Resistant Depression
Brief Summary: LQD is a multicentre randomised clinical trial comparing the clinical and cost effectiveness of lithium versus quetiapine when used as add-on therapies to antidepressant medication for patients with treatment resistant depression. The Lithium versus Quetiapine in Depression (LQD) study will assess patients over 12 months to establish which (if any) treatment is more likely to improve TRD over a long duration of time. Professor Anthony Cleare is the Chief Investigator and recruitment began in November 2016.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: lamotrigine, Drug: paroxetine | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo, Drug: paroxetine | Intervention Type: DRUG; Name: lamotrigine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: paroxetine; Assigned to Arm(s): 1, 2
B: Arm Label: lithium plus usual care; Type: EXPERIMENTAL; Interventions: Drug: lithium | Arm Label: usual care without lithium therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: usual care | Intervention Type: DRUG; Name: lithium; Assigned to Arm(s): lithium plus usual care | Intervention Type: DRUG; Name: usual care; Assigned to Arm(s): usual care without lithium therapy
C: Arm Label: Lithium; Type: ACTIVE_COMPARATOR; Interventions: Drug: Lithium | Arm Label: Quetiapine; Type: EXPERIMENTAL; Interventions: Drug: Quetiapine | Intervention Type: DRUG; Name: Quetiapine; Assigned to Arm(s): Quetiapine | Intervention Type: DRUG; Name: Lithium; Assigned to Arm(s): Lithium
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Aripiprazole (Fixed dose) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Aripiprazole (Titrated dose) | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Aripiprazole (Fixed dose); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Aripiprazole (Titrated dose); Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 3

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Optimal Fecal Microbiota Transplant Dosing for Mild to Moderate Ulcerative Colitis
Brief Summary: This is a prospective unblinded, randomized trial for the use of Fecal Microbiota Transplantation (FMT) for the treatment of Ulcerative Colitis (UC), in combination with or without antibiotic pretreatment.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: Fecal Microbiota Transplantation (FMT), OpenBiome, Other: pretreatment antibiotics | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Biological: Fecal Microbiota Transplantation (FMT), OpenBiome | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Biological: Fecal Microbiota Transplantation (FMT), OpenBiome, Other: pretreatment antibiotics | Arm Label: 4; Type: EXPERIMENTAL; Interventions: Biological: Fecal Microbiota Transplantation (FMT), OpenBiome | Intervention Type: BIOLOGICAL; Name: Fecal Microbiota Transplantation (FMT), OpenBiome; Assigned to Arm(s): 1, 2, 3, 4 | Intervention Type: OTHER; Name: pretreatment antibiotics; Assigned to Arm(s): 1, 3
B: Arm Label: Metronidazole+doxycylcine+terbinafine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metronidazole, Drug: Doxycycline, Drug: Terbinafine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): Metronidazole+doxycylcine+terbinafine | Intervention Type: DRUG; Name: Doxycycline; Assigned to Arm(s): Metronidazole+doxycylcine+terbinafine | Intervention Type: DRUG; Name: Terbinafine; Assigned to Arm(s): Metronidazole+doxycylcine+terbinafine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Colonoscopy; Type: EXPERIMENTAL; Interventions: Drug: Fecal Microbiota Transplant (FMT) | Arm Label: Nasogastric Tube (NGT); Type: EXPERIMENTAL; Interventions: Drug: Fecal Microbiota Transplant (FMT) | Intervention Type: DRUG; Name: Fecal Microbiota Transplant (FMT); Assigned to Arm(s): Colonoscopy, Nasogastric Tube (NGT)
D: Arm Label: Study Participants; Type: EXPERIMENTAL; Interventions: Drug: Gut Microbial Transplantation | Intervention Type: DRUG; Name: Gut Microbial Transplantation; Assigned to Arm(s): Study Participants

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Comprehensive Disease Management Program to Improve Quality of Life in Disparity Hispanic and African-American Patients Admitted With Exacerbation of Chronic Pulmonary Diseases
Brief Summary: Chronic Obstructive Pulmonary Disease (COPD), also known as emphysema, is the leading cause of hospitalization for older adults in the U.S., and a leading cause of death. Although there is no cure for COPD, a program called pulmonary rehabilitation (PR), which combines exercise and education, can help decrease re-hospitalizations and improve patients' quality of life. Unfortunately, very few COPD Latino and African-American patients actually get PR. These patients are unlikely to get referrals or to be able to attend PR due to lack of insurance, lack of transportation, or lack of a PR center in their area. Telehealth is a way of using computers to deliver healthcare long-distance, eliminating the need for a patient to travel to receive care. By using telehealth for PR, the patient can exercise on a stationary bike in his or her home, while being supervised by videoconference by a respiratory therapist (RT). The RT can "see" the patient, and deliver education by videoconference, and the patient can "see" the RT, so the patient does not need to leave home to get PR.


Options:
A: Arm Label: Usual Care; Type: OTHER; Interventions: Other: Usual Care | Arm Label: BREATHE program; Type: EXPERIMENTAL; Interventions: Other: BREATHE program | Intervention Type: OTHER; Name: BREATHE program; Assigned to Arm(s): BREATHE program | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care
B: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Telehealth Pulmonary Rehabilitation | Intervention Type: OTHER; Name: Telehealth Pulmonary Rehabilitation; Assigned to Arm(s): Intervention
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Device: half-yearly monitoring routine | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: half-yearly monitoring routine; Assigned to Arm(s): A
D: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Active implementation of a guideline for chronic disease | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: External control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Active implementation of a guideline for chronic disease; Assigned to Arm(s): Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Comprehensive Disease Management Program to Improve Quality of Life in Disparity Hispanic and African-American Patients Admitted With Exacerbation of Chronic Pulmonary Diseases
Brief Summary: Chronic Obstructive Pulmonary Disease (COPD), also known as emphysema, is the leading cause of hospitalization for older adults in the U.S., and a leading cause of death. Although there is no cure for COPD, a program called pulmonary rehabilitation (PR), which combines exercise and education, can help decrease re-hospitalizations and improve patients' quality of life. Unfortunately, very few COPD Latino and African-American patients actually get PR. These patients are unlikely to get referrals or to be able to attend PR due to lack of insurance, lack of transportation, or lack of a PR center in their area. Telehealth is a way of using computers to deliver healthcare long-distance, eliminating the need for a patient to travel to receive care. By using telehealth for PR, the patient can exercise on a stationary bike in his or her home, while being supervised by videoconference by a respiratory therapist (RT). The RT can "see" the patient, and deliver education by videoconference, and the patient can "see" the RT, so the patient does not need to leave home to get PR.


Options:
A: Arm Label: COPD Web; Type: EXPERIMENTAL; Interventions: Behavioral: COPD Web | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: COPD Web; Assigned to Arm(s): COPD Web
B: Arm Label: Home-based pulmonary rehabilitation; Type: EXPERIMENTAL; Interventions: Behavioral: Home-based pulmonary rehabilitation | Arm Label: Hospital-based pulmonary rehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Hospital-based pulmonary rehabilitation | Intervention Type: BEHAVIORAL; Name: Home-based pulmonary rehabilitation; Assigned to Arm(s): Home-based pulmonary rehabilitation | Intervention Type: BEHAVIORAL; Name: Hospital-based pulmonary rehabilitation; Assigned to Arm(s): Hospital-based pulmonary rehabilitation
C: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Telehealth Pulmonary Rehabilitation | Intervention Type: OTHER; Name: Telehealth Pulmonary Rehabilitation; Assigned to Arm(s): Intervention
D: Arm Label: Control group (Group A); Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Arm Label: Intervention group (Group B); Type: OTHER; Interventions: Other: Home-based telehealth program, Other: Home-based rehabilitation, Other: Usual care | Intervention Type: OTHER; Name: Home-based telehealth program; Assigned to Arm(s): Intervention group (Group B) | Intervention Type: OTHER; Name: Home-based rehabilitation; Assigned to Arm(s): Intervention group (Group B) | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Control group (Group A), Intervention group (Group B)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Comprehensive Disease Management Program to Improve Quality of Life in Disparity Hispanic and African-American Patients Admitted With Exacerbation of Chronic Pulmonary Diseases
Brief Summary: Chronic Obstructive Pulmonary Disease (COPD), also known as emphysema, is the leading cause of hospitalization for older adults in the U.S., and a leading cause of death. Although there is no cure for COPD, a program called pulmonary rehabilitation (PR), which combines exercise and education, can help decrease re-hospitalizations and improve patients' quality of life. Unfortunately, very few COPD Latino and African-American patients actually get PR. These patients are unlikely to get referrals or to be able to attend PR due to lack of insurance, lack of transportation, or lack of a PR center in their area. Telehealth is a way of using computers to deliver healthcare long-distance, eliminating the need for a patient to travel to receive care. By using telehealth for PR, the patient can exercise on a stationary bike in his or her home, while being supervised by videoconference by a respiratory therapist (RT). The RT can "see" the patient, and deliver education by videoconference, and the patient can "see" the RT, so the patient does not need to leave home to get PR.


Options:
A: Arm Label: Telerehabilitation programme; Type: EXPERIMENTAL; Interventions: Device: Telerehabilitation programme | Arm Label: Control group traditional rehabilitation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Telerehabilitation programme; Assigned to Arm(s): Telerehabilitation programme
B: Arm Label: AB sequence; Type: EXPERIMENTAL; Interventions: Other: Usual care followed by the use of HeartHab application | Arm Label: BA sequence; Type: EXPERIMENTAL; Interventions: Other: Use of HeartHab application followed by usual care | Intervention Type: OTHER; Name: Use of HeartHab application followed by usual care; Assigned to Arm(s): BA sequence | Intervention Type: OTHER; Name: Usual care followed by the use of HeartHab application; Assigned to Arm(s): AB sequence
C: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Telehealth Pulmonary Rehabilitation | Intervention Type: OTHER; Name: Telehealth Pulmonary Rehabilitation; Assigned to Arm(s): Intervention
D: Arm Label: BESMILE-HF group; Type: EXPERIMENTAL; Interventions: Behavioral: BESMILE-HF program, Drug: Usual medications | Arm Label: Control; Type: OTHER; Interventions: Drug: Usual medications | Intervention Type: BEHAVIORAL; Name: BESMILE-HF program; Assigned to Arm(s): BESMILE-HF group | Intervention Type: DRUG; Name: Usual medications; Assigned to Arm(s): BESMILE-HF group, Control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prophylactic Negative Pressure Wound Therapy in Obese Women at Cesarean: a Multicenter Randomized Trial
Brief Summary: The Prophylactic Negative Pressure Wound Therapy in Obese Women at Cesarean Trial is a large pragmatic multi-center randomized clinical trial designed to evaluate the effectiveness, safety and cost-effectiveness of prophylactic negative pressure wound therapy (NPWT) - a closed, sealed system that applies negative pressure to the wound surface via a single-use, battery-powered, portable device - to decrease surgical site infections (SSIs) in obese women.


Options:
A: Arm Label: Negative Pressure Wound Therapy; Type: EXPERIMENTAL; Interventions: Device: Negative pressure wound therapy | Arm Label: Standard dressing; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Negative pressure wound therapy; Assigned to Arm(s): Negative Pressure Wound Therapy
B: Arm Label: Standard Dressing; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Postoperative NPWT dressing; Type: EXPERIMENTAL; Interventions: Device: Postoperative Negative Pressure Wound Therapy KCI NANOVA | Intervention Type: DEVICE; Name: Postoperative Negative Pressure Wound Therapy KCI NANOVA; Assigned to Arm(s): Postoperative NPWT dressing
C: Arm Label: Simple dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Smith & Nephew PICO Negative wound pressure versus standard dresing, Device: PREVENA Negative pressure wound versus standard dressing | Arm Label: PICO Dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: PREVENA Negative pressure wound versus standard dressing | Arm Label: PREVENA Dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Smith & Nephew PICO Negative wound pressure versus standard dresing | Intervention Type: DEVICE; Name: Smith & Nephew PICO Negative wound pressure versus standard dresing; Assigned to Arm(s): PREVENA Dressing, Simple dressing | Intervention Type: DEVICE; Name: PREVENA Negative pressure wound versus standard dressing; Assigned to Arm(s): PICO Dressing, Simple dressing
D: Arm Label: Prophylactic NPWT; Type: EXPERIMENTAL; Interventions: Device: Prophylactic NPWT | Arm Label: Standard Dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard Dressing | Intervention Type: DEVICE; Name: Prophylactic NPWT; Assigned to Arm(s): Prophylactic NPWT | Intervention Type: DEVICE; Name: Standard Dressing; Assigned to Arm(s): Standard Dressing

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Perioperative Endothelial Dysfunction in Patients Undergoing Major Acute Abdominal Surgery. The POETRY Abdominal Study
Brief Summary: The aim of the clinical study is:

1. to examine the association between postoperative endothelial function, indirectly measured by reactive hyperemia index, and major adverse cardiovascular events including myocardial injury and cardiac death within 30, 90 and 365 days of acute abdominal surgery.
2. to examine the association between postoperative endothelial function, indirectly measured by reactive hyperemia index, and non-cardiovascular complications including non-cardiac death within 30, 90 and 365 days of acute abdominal surgery.
3. to examine the importance of the postoperative blood glucose level and the pulmonary function for postoperative complications and death within 30, 90 and 365 days of acute abdominal surgery.
4. to examine the association between postoperative endothelial function, pulmonary function and blood glucose level
5. the qualitative part of the study will examine the postoperative subjective symptoms including acute and chronic pain, quality of recovery and functional status, depressive thoughts and post-traumatic stress disorder.


Options:
A: N/A
B: Intervention Type: PROCEDURE; Name: Acute abdominal surgery; Assigned to Arm(s): N/A
C: N/A
D: Arm Label: patients with hip fracture; Type: N/A; Interventions: Other: observation | Intervention Type: OTHER; Name: observation; Assigned to Arm(s): patients with hip fracture

Answer: B